NVIGEN X™ is enabled by the state-of-the-art molecularly engineered nanoparticles, MagVigen™ and MyQuVigen™, to efficiently capture and identify molecular information from proteins, cells and nucleic acids. We are developing NVIGEN X™ into accurate, automated and FDA approved clinical instruments and reagent kits deploy-able at hundreds and thousands of hospitals, turning fatal cancers into manageable diseases.
Highly Sensitive Cancer Profiling for the Precise Curative Solution
From a single vial of whole blood sample, NVIGEN X™ applies 3 streams of extraction and analysis.
- CTC Phenotyping
- CTC/ctDNA Gene Data
- Tissue Sample, Protein Data and Custom Assay
Figure 1. NVIGEN X™ Robust Targeted Sequencing Assay for Highly Precise Variant Detection with Ready to Use or Custom Panels.
- High yield capture
- High specificity
- Simultaneous immunomagentic CTC isolation and cell surface marker detection
- High yield and quality extraction
- Optimal NGS library yield
- Perfect for PCR and NGS assays
Figure 2.Highly Sensitive qPCR Detection Combining NVIGEN cfDNA Extraction and Target Capture with MagVigen TM –Streptavidin Nanobeads.
Figure 3.Clean Bioanalyzer Profiles Showing Higher Yield of cfDNA Extracted with NVIGEN Kit vs. Q-ccf Kit.
Figure 4.Higher Yield and Quality NGS Library from cfDNA Extracted with NVIGEN Kit vs. Q-ccf Kit. Library Cleanup Performed Using MagVigen TM –Easy DNA Cleanup Kit.